In a significant yet cautious step amidst the evolving landscape of cryptocurrency, Acurx Pharmaceuticals has made headlines by approving the acquisition of up to $1 million in bitcoin as a part of their treasury reserve. This decision, made by the company’s board, signals a growing recognition of bitcoin’s potential as a credible treasury asset. CEO
Investing
In a surprising turn of events, the nomination of Robert F. Kennedy Jr. as Health and Human Services (HHS) Secretary by President-elect Donald Trump has sparked significant speculation regarding changes in U.S. public health policy. Most notably, his proposal to advocate for the removal of fluoride from public water systems has raised eyebrows in the
The recent fluctuations in the stock market post-election reflect the unpredictability of investor sentiment and economic indicators. Despite the current turbulence, seasoned investors can unearth opportunities amidst the chaos. It is essential to maintain a macro view rather than getting bogged down by temporary volatility. By leveraging insights from well-regarded analysts, investors can tailor their
On a tumultuous trading day, stocks of major processed food companies plummeted, driven by investor concerns surrounding potential regulatory changes under President-elect Donald Trump and his ally, Robert F. Kennedy Jr. As the market closed on Friday, industry giants like PepsiCo experienced a drop exceeding 3%, while Coca-Cola’s shares fell by about 1%. This sharp
David Einhorn, the prominent hedge fund manager and founder of Greenlight Capital, has experienced a challenging year as he tactically navigates what he perceives to be the highest valuation levels in the stock market throughout his career. By the end of the third quarter of 2024, Greenlight Capital reported a modest return of just 9%,
As the United States transitions into a new administration, many market analysts are scrutinizing the potential ramifications of President-elect Donald Trump’s policies on the stock market. Historically, Trump has positioned himself as a staunch proponent of business interests, an aspect that could lead to significant upward movement in market indices. Jeremy Siegel, a well-respected finance
Amidst fluctuating market trends and unpredictable economic indicators, investors continuously search for strategies to fortify their portfolios. With the recent uptick in stock averages following significant political developments, many are turning toward dividend stocks as a practical hedge. This article explores the merits of dividend-paying stocks and highlights three distinct companies that have garnered positive
Verona Pharma stands out as a significant player in the biopharmaceutical landscape, dedicating its resources to tackling respiratory diseases that demand innovative solutions. Founded in 2005 and headquartered in London, this company is currently in the clinical stage, developing therapies aimed at addressing unmet medical needs among patients suffering from chronic obstructive pulmonary disease (COPD),
The investment landscape has witnessed dramatic changes over the last decade, with private investments surging from $4 trillion to a staggering $14 trillion. This rapid growth has been primarily fueled by institutional investors seeking avenues for differentiated returns and alpha generation. As a result, a significant shift is occurring in the investor demographic, with individual
In the ever-evolving tapestry of American politics, the recent shifts in Congressional control hold significant implications for the financial landscape of the nation. With Republicans potentially securing power in the House, financial experts like Jeffrey Gundlach, CEO of DoubleLine Capital, foresee a radical transformation in federal spending dynamics. His analysis, shared during an interview on